TSEN2 inhibitors are a class of chemical compounds designed to target and inhibit the activity of the TSEN2 protein, which is a component of the tRNA-splicing endonuclease complex. TSEN2 plays a critical role in the process of tRNA maturation by catalyzing the precise cleavage of introns from precursor tRNAs. This step is essential for the production of functional tRNAs, which are crucial for protein synthesis in all cells. Inhibition of TSEN2 disrupts this process, leading to the accumulation of unspliced tRNA precursors and impairing the proper translation of genetic information into proteins. By targeting TSEN2, these inhibitors affect a fundamental aspect of RNA processing, which can have significant downstream effects on cellular metabolism and gene expression.
Chemically, TSEN2 inhibitors are designed to interact with specific regions of the protein that are critical for its enzymatic activity. These inhibitors may bind to the active site of TSEN2, blocking its ability to cleave tRNA precursors, or they may target other regions involved in protein-protein interactions within the tRNA-splicing complex. The design of these inhibitors requires a detailed understanding of the three-dimensional structure of TSEN2, as well as the specific biochemical pathways in which it operates. Researchers focus on achieving high specificity in these inhibitors to ensure that they selectively target TSEN2 without affecting other components of the tRNA-splicing machinery. By studying the effects of TSEN2 inhibitors, scientists can gain valuable insights into the mechanics of RNA processing, tRNA maturation, and the broader role of TSEN2 in maintaining cellular protein synthesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferase, potentially altering gene methylation and expression, including that of TSEN2. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is another histone deacetylase inhibitor that may influence gene expression, potentially including TSEN2. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor that might change the methylation pattern and expression of the TSEN2 gene. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide interferes with topoisomerase II, potentially affecting DNA replication and transcription, including TSEN2 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II transcription elongation, potentially leading to decreased TSEN2 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin is an inhibitor of RNA polymerase II, which could reduce the transcription of genes like TSEN2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid affects gene expression via nuclear receptors and might influence TSEN2 transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor that may affect gene expression patterns, potentially including TSEN2. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin induces premature termination of protein synthesis, potentially leading to decreased levels of TSEN2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and protein synthesis, potentially affecting TSEN2 expression. | ||||||